推进大麻科学的契机——美国药品管理局重新安排管制级别 - Suppr

Suppr

超能文献

An Opportunity to Advance Cannabis Science-DEA Rescheduling.

作者信息

Hill Kevin P, Puli Anshul V

机构信息

Division of Addiction Psychiatry, Harvard Medical School, Boston, Massachusetts.

Department of Psychiatry, Beth Israel Deaconess Medical Center, Boston, Massachusetts.

出版信息

JAMA Psychiatry. 2025 Apr 1;82(4):331-332. doi: 10.1001/jamapsychiatry.2024.4691.

DOI:10.1001/jamapsychiatry.2024.4691

PMID:39908034

Abstract

摘要

相似文献

An Opportunity to Advance Cannabis Science-DEA Rescheduling.

JAMA Psychiatry. 2025 Apr 1;82(4):331-332. doi: 10.1001/jamapsychiatry.2024.4691.

Trends in hydrocodone combination product exposures reported to California Poison Control System (CPCS) following DEA rescheduling.

Clin Toxicol (Phila). 2021 Apr;59(4):313-319. doi: 10.1080/15563650.2020.1803350. Epub 2020 Aug 25.

Decreased Opioid Prescribing in a Pediatric Emergency Department After the Rescheduling of Hydrocodone.

J Emerg Med. 2017 Apr;52(4):547-553. doi: 10.1016/j.jemermed.2016.08.026. Epub 2016 Oct 7.

Pharmacists' perceptions regarding the impact of hydrocodone rescheduling on prescription volume, workflow management, and patient outcomes.

J Am Pharm Assoc (2003). 2017 Mar-Apr;57(2S):S51-S62. doi: 10.1016/j.japh.2017.01.020.

Preparation and Distribution of Cannabis and Cannabis-Derived Dosage Formulations for Investigational and Therapeutic Use in the United States.

Front Pharmacol. 2016 Aug 31;7:285. doi: 10.3389/fphar.2016.00285. eCollection 2016.

Effects of the Federal Government's Move to Reschedule Cannabis: A Commentary.

J Stud Alcohol Drugs. 2025 Jan;86(1):8-12. doi: 10.15288/jsad.24-00346. Epub 2024 Oct 15.

Drug Enforcement Administration Rescheduling of Hydrocodone Combination Products Is Associated With Changes in Physician Pain Management Prescribing Preferences.

J Pain Palliat Care Pharmacother. 2019 Mar-Jun;33(1-2):22-31. doi: 10.1080/15360288.2019.1615027. Epub 2019 Aug 27.

Legal and Regulatory Issues Governing Cannabis and Cannabis-Derived Products in the United States.

Front Plant Sci. 2019 Jun 14;10:697. doi: 10.3389/fpls.2019.00697. eCollection 2019.

Schedules of controlled substances: rescheduling of buprenorphine from schedule V to schedule III. Final rule.

Fed Regist. 2002 Oct 7;67(194):62354-70.

U.S. Pharmacist Opinions Regarding the Rescheduling of Hydrocodone Combination Products: A Pilot Study.

Pharmacy (Basel). 2015 Aug 28;3(3):129-136. doi: 10.3390/pharmacy3030129.

引用本文的文献

Under the Influence: Cognitive Effects of Medical Marijuana on Developing Minds.

J Pediatr Pharmacol Ther. 2025 Aug;30(4):440-449. doi: 10.5863/JPPT-25-01209. Epub 2025 Aug 11.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

An Opportunity to Advance Cannabis Science-DEA Rescheduling.

作者信息

Hill Kevin P, Puli Anshul V

机构信息

Division of Addiction Psychiatry, Harvard Medical School, Boston, Massachusetts.

Department of Psychiatry, Beth Israel Deaconess Medical Center, Boston, Massachusetts.

出版信息

JAMA Psychiatry. 2025 Apr 1;82(4):331-332. doi: 10.1001/jamapsychiatry.2024.4691.

DOI:10.1001/jamapsychiatry.2024.4691

PMID:39908034

Abstract

摘要

相似文献

An Opportunity to Advance Cannabis Science-DEA Rescheduling.

JAMA Psychiatry. 2025 Apr 1;82(4):331-332. doi: 10.1001/jamapsychiatry.2024.4691.

Trends in hydrocodone combination product exposures reported to California Poison Control System (CPCS) following DEA rescheduling.

Clin Toxicol (Phila). 2021 Apr;59(4):313-319. doi: 10.1080/15563650.2020.1803350. Epub 2020 Aug 25.

Decreased Opioid Prescribing in a Pediatric Emergency Department After the Rescheduling of Hydrocodone.

J Emerg Med. 2017 Apr;52(4):547-553. doi: 10.1016/j.jemermed.2016.08.026. Epub 2016 Oct 7.

Pharmacists' perceptions regarding the impact of hydrocodone rescheduling on prescription volume, workflow management, and patient outcomes.

J Am Pharm Assoc (2003). 2017 Mar-Apr;57(2S):S51-S62. doi: 10.1016/j.japh.2017.01.020.

Preparation and Distribution of Cannabis and Cannabis-Derived Dosage Formulations for Investigational and Therapeutic Use in the United States.

Front Pharmacol. 2016 Aug 31;7:285. doi: 10.3389/fphar.2016.00285. eCollection 2016.

Effects of the Federal Government's Move to Reschedule Cannabis: A Commentary.

J Stud Alcohol Drugs. 2025 Jan;86(1):8-12. doi: 10.15288/jsad.24-00346. Epub 2024 Oct 15.

Drug Enforcement Administration Rescheduling of Hydrocodone Combination Products Is Associated With Changes in Physician Pain Management Prescribing Preferences.

J Pain Palliat Care Pharmacother. 2019 Mar-Jun;33(1-2):22-31. doi: 10.1080/15360288.2019.1615027. Epub 2019 Aug 27.

Legal and Regulatory Issues Governing Cannabis and Cannabis-Derived Products in the United States.

Front Plant Sci. 2019 Jun 14;10:697. doi: 10.3389/fpls.2019.00697. eCollection 2019.

Schedules of controlled substances: rescheduling of buprenorphine from schedule V to schedule III. Final rule.

Fed Regist. 2002 Oct 7;67(194):62354-70.

U.S. Pharmacist Opinions Regarding the Rescheduling of Hydrocodone Combination Products: A Pilot Study.

Pharmacy (Basel). 2015 Aug 28;3(3):129-136. doi: 10.3390/pharmacy3030129.

引用本文的文献

Under the Influence: Cognitive Effects of Medical Marijuana on Developing Minds.

J Pediatr Pharmacol Ther. 2025 Aug;30(4):440-449. doi: 10.5863/JPPT-25-01209. Epub 2025 Aug 11.